JUBILANT REPORTS RECORD PERFORMANCE IN FY'19
Revenue up 21% YoY to Rs. 9,111 Crore; EBITDA up 14% YoY to Rs 1,775 Crore
Normalised PAT at Rs. 855 Crore with EPS at Rs. 54 per share
Q4'FY19 Revenue at Rs 2,386...
The Pharma Times provides with the latest breaking news and videos straight from the Pharma industry including in depth coverage, news, views, reviews market dynamics, research and design of this industry.